Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Consultant Cardiologist and Director of the Hypertension Service
Added: 5 months ago Source:  Radcliffe CVRM
Late-breaking results from the pivotal Phase III FINE-ONE study show that finerenone significantly reduces the urine albumin-to-creatinine ratio (UACR) in adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D).² The findings, presented at the American Society of Nephrology’s Kidney Week 2025, mark the first positive Phase III results for a new therapy in this high-risk… View more
Job title: Head of Cardiology
Personal History Prof. Kevin Vernooy is based in Maastricht, The Netherlands, where he works as Head of Cardiology for Maastricht UMC+. Academic History Prof. Kevin Vernooy became a medical doctor in 2003, after completing his studies at Maastricht University. He completed his PhD in 2006 on cardiac resynchronisation therapy at Maastricht University. In 2012, he finished his… View more
Job title: Professor-Emeritus in the Department of Pharmacology
Dr Shengxian Tu, PhD, FACC, FESC is Professor of biomedical engineering at Shanghai Jiao Tong University in Shanghai, China.Dr Tu received his PhD at the Leiden University Medical Center with cum laude. He is the inventor of both QFR and OFR techniques that allow for fast computation of fractional flow reserve from X-ray angiography and intracoronary optical coherence tomography, respectively. View more
Job title: Director, Cardiac Catheterization & Interventional Cardiology
Dr Ignacio J Amat Santos is an interventional cardiologist based in Spain. He is currently the director of cardiac catheterization and interventional cardiology at Hospital Clínico Valladolid. Dr Amat Santos is the director of cardiac catheterization and interventional cardiology at Hospital Clínico Valladolid. He has clinical and research experience in the percutaneous treatment of coronary… View more
Author(s): Ellen Linnea Freese Ballegaard Added: 11 months ago
ERA 2025 - Dr Ellen Linnea Freese Ballegaard (Copenhagen University Hospital, Copenhagen, DK) joins us to discuss a study investigating guideline-based management of CKD and evaluate the associated risk of cardio-renal outcomes. 315,636 patients were identified from nationwide Danish health care registers between 2011 and 2022 and enrolled in the study. The primary outcome measure was a composite… View more
Added: 2 weeks ago Source:  Radcliffe CKM
Mirjam Boros, Radcliffe CardiologyA post hoc secondary analysis of the SOUL trial has found that once-daily oral semaglutide is associated with early and sustained improvements in multiple cardiovascular (CV) risk factors in high-risk patients with type 2 diabetes (T2D).¹ These findings help to explain the mechanisms behind the primary trial results, which showed a 14% reduction in major adverse… View more
Job title: Post Doctoral Researcher
Dr. Alexander van Rosendael is a cardiologist in training and specialises in non-invasive imaging of coronary artery disease, particularly through coronary CT. He earned his PhD for research conducted at the Leiden University Medical Center in the Netherlands and the Weill Cornell Medicine, Dalio Institute for Cardiovascular Imaging in New York, US. He has participated in various international… View more
Job title: Director of Heart and Vascular Center
Dr Jose L Navia is the Director of the Heart and Vascular Center at Cleveland Clinic Florida; Chairman of Cardiothoracic Surgery in Florida; and the S. Donald Sussman Distinguished Chair in Heart and Vascular Research. Dr Navia is also Professor of Surgery at Cleveland Clinic Lerner College of Medicine. Dr Navia earned his medical degree from the School of Medicine at the National University of… View more